BeOne Medicines AG
BeOne Medicines's Group Entities Data Preview
As of Invalid Date, Tracenable has captured detailed data on BeOne Medicines's corporate ownership structure, offering an in-depth view of its significant subsidiaries and their importance within the group. a
The dataset includes information on 61 subsidiaries, identified as material based on their financial importance, operational scale, or strategic contribution to BeOne Medicines's consolidated operations. a
Tracenable's data also records the effective ownership percentages that BeOne Medicines holds across these entities, providing transparency into its corporate control, ownership hierarchy, and group governance practices. a
| Entity Name | Country | Type | Ownership | LEI | PermID |
|---|---|---|---|---|---|
Copy restricted. Please purchase to unlock this data.  a | CAN | Subsidiary | 100% | 0000000 | 0000000 |
Copy restricted. Please purchase to unlock this data.  a | CHL | Subsidiary | 100% | 0000000 | 0000000 |
Copy restricted. Please purchase to unlock this data.  a | CYM | Subsidiary | 100% | 0000000 | 0000000 |
Copy restricted. Please purchase to unlock this data.  a | ARG | Subsidiary | 100% | 0000000 | 0000000 |
Copy restricted. Please purchase to unlock this data.  a | AUS | Subsidiary | 100% | 0000000 | 0000000 |
Copy restricted. Please purchase to unlock this data.  a | AUT | Subsidiary | 100% | 0000000 | 0000000 |
Copy restricted. Please purchase to unlock this data.  a | CHN | Subsidiary | 100% | 0000000 | 0000000 |
Copy restricted. Please purchase to unlock this data.  a | BEL | Subsidiary | 100% | 0000000 | 0000000 |
Copy restricted. Please purchase to unlock this data.  a | CHN | Subsidiary | 100% | 0000000 | 0000000 |
Copy restricted. Please purchase to unlock this data.  a | BRA | Subsidiary | 100% | 0000000 | 0000000 |
Copy restricted. Please purchase to unlock this data.  a | COL | Subsidiary | 100% | 0000000 | 0000000 |
Copy restricted. Please purchase to unlock this data.  a | ESP | Subsidiary | 100% | 0000000 | 0000000 |
0000000 | 0000000 | 0000000 | 0000000 | 0000000 | 0000000 |
0000000 | 0000000 | 0000000 | 0000000 | 0000000 | 0000000 |
| Showing 12 out of 61 entities. Get complete coverage in the full dataset. | |||||
Verified Sources Behind BeOne Medicines’s Group Entities Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore BeOne Medicines’s data sources below and access millions more through our Disclosure Search.
Insights into BeOne Medicines's Group Entities Location
Tracenable's group entities dataset provides geographic insights into BeOne Medicines's significant subsidiaries, revealing their location around the world. a
In total, the BeOne Medicines group includes 61 significant subsidiaries distributed across 35 countries, illustrating the company's governance network, operational footprint, and geographical consolidation structure. a
This visualization highlights the geographical distribution of BeOne Medicines's corporate structure, helping assess its international exposure, operational reach, and cross-border governance landscape. a
How geographically diverse is BeOne Medicines's corporate structure?
In 2024, Tracenable identified that the BeOne Medicines group consisted of 61 significant subsidiaries, located across 35 countries. a
This represents a focused geographic presence, reflecting the company's core operational centers or key strategic markets rather than a full view of its global entity network. a
What does the geographic footprint of BeOne Medicines reveal about its business operations?
BeOne Medicines's significant subsidiaries are primarily located in Asia and Europe, which together host 63.93% of its material entities. a
This concentration suggests that the company's strategic and operational priorities are centered in these key markets, consistent with its focus on financially material or high-impact operations.
How transparent is BeOne Medicines about its group entities and ownership structure?
BeOne Medicines exhibits a limited level of transparency concerning its corporate ownership structure.
The disclosure covers only a small number of significant subsidiaries, typically those with material financial or operational relevance. a
Without full group hierarchy or equity details, it offers a restricted view of BeOne Medicines's broader ownership network, making it harder to assess the company's consolidated structure or cross-entity control.
Does BeOne Medicines maintain entities in low-tax or offshore jurisdictions?
Yes. Tracenable's data shows that 6 entities ( 9.84%) are registered in jurisdictions commonly classified as low-tax or offshore financial centers, such as Cayman Islands. a
This may indicate tax optimization strategies or the use of special-purpose vehicles (SPVs) within BeOne Medicines's ownership structure.